&format=webp&quality=medium)
Stocks to Watch on Wednesday (March 4, 2026) Amid Middle East Tensions: Domestic equity benchmarks are likely to start Wednesday's session on a cautious note when they reopen for trade following a mid-week trading holiday for Holi. An ongoing military conflict in the Middle East, following the joint US-Israel attack against Iran that left its Supreme Leader killed, is set to keep investors on edge amid continued crude oil jitters and flight disruptions. Analysts say that although the attack against Iran was largely factored in, the severity of multi-pronged escalations will be closely tracked by investors.
Experts say the market has largely absorbed the initial geopolitical shock of the Middle East war, with limited downside unless oil prices spike sharply. They also believe that the Israel-Iran conflict is unlikely to escalate into a full-scale war, suggesting caution but continued SIPs. Read more
GIFT Nifty futures -- an early indicator of the benchmark Nifty50 index -- were seen trading 397.5 points, or 1.6 per cent, at 24,595 at the last count, suggesting a sharply negative opening ahead on Dalal Street.
Here's the list of stocks in focus:
The Income Tax Department has conducted searches at the company’s registered office, subsidiaries and two manufacturing units.
Both auto giants have issued clarifications after reports suggested that Indonesia had cancelled a vehicle import order. No official communication has been received regarding cancellation of the offer, with deliveries set to commence shortly as per the originally scheduled offer, according to the companies.
The company, along with Breckenridge, has launched Pomalidomide Capsules in the US. A generic version of Celgene’s Pomalyst, the drug is used for the treatment of multiple myeloma and Kaposi sarcoma.
The US market size for this drug is estimated at Rs 29,500 crore.
The company has rolled out the Roadster range, starting at Rs 79,999.
The company has launched the Shaurya series under the Powertrac brand for paddy farming in the southern regions of the country.
The company has merged MarTech capabilities of Adara and Sojern to form a unified unit under the Sojern brand. It claims to have created the world’s largest travel intent data source.
The company has received a Letter of Award from the Delhi Development Authority (DDA) for developing a five-star hotel on a 2.5-acre land parcel in Delhi's Dwarka Sector 2.
The Defence Ministry has signed a Rs 2,901 crore deal for six ALH MK III helicopters. The contract is for the Indian Coast Guard.
Shyamkant Giri has resigned as the company's CEO.
The company is set to acquire a minority stake in luxury skincare company RAS Beauty for Rs 60 crore, through Dabur Venture.
The Maharashtra GST Department has issued no notice against the company after completed its investigation.
The investigation will have no financial impact on the company.
The pharma company has entered an agreement with Kemwell Biopharma for a 60:40 partnership.
The partnership will focus on the manufacturing, development and commercialisation of biologics products.
The company has placed the lowest bid for limestone blocks in Assam.
The company has received the RBI's nod to undertake factoring business.
The company has invested a total of Rs 9 crore towards capacity expansion.
IndiGo shares -- which took the biggest beating among blue-chip stocks in Monday's trade -- are set to be in focus once again.
Indian carriers are further planning 58 flights on March 4, including 30 by IndiGo, and 23 by Air India and Air India Express. Foreign carriers operating between India and the Gulf region are also undertaking limited operations, subject to operational and airspace considerations. The Civil Aviation Ministry is in continuous touch with airlines and is closely monitoring airfares to ensure that there is no undue surge in ticket prices during this period.